Literature DB >> 8891076

Coexistence of Huntington's disease and familial amyotrophic lateral sclerosis: case presentation.

A Rubio1, K Steinberg, D A Figlewicz, M E MacDonald, T Greenamyre, R Hamill, I Shoulson, J M Powers.   

Abstract

We present the clinical, molecular genetic and neuropathological findings of an 81-year-old man with concurrent Huntington's disease (HD) and familial amyotrophic lateral sclerosis (FALS). His mother had been diagnosed clinically as having ALS. There was no known family history of HD, but a maternal uncle had died in a chronic care psychiatric hospital. The diagnosis of HD in the patient was suspected at age 66, after 8 years of personality change, hallucinations, agitation, cognitive decline and choreoathetosis. No symptoms of motor neuron disease were noticed at that time, but progressive weakness developed later. Postmortem examination revealed cerebral atrophy, marked atrophy of basal ganglia (grade 3), and atrophy of brain stem and spinal cord. The neostriatum displayed massive neuronal loss and gliosis. The neocortex showed changes characteristic of Alzheimer's disease. Pathological lesions also included loss of neurons and gliosis in the anterior horns, Clarke's columns and the hypoglossal nuclei; degeneration of the lateral corticospinal tracts, dorsal spinocerebellar tracts and fasciculus gracilis; and rare Bunina bodies and ubiquitin-positive filamentous skeins in motor-neuron perikarya. Molecular analysis demonstrated chromosome 4p16.3 expansion of trinucleotide repeats characteristic of HD. Analysis of Cu,Zn superoxide dismutase gene and heavy neurofilament subunit gene failed to demonstrate mutations. The concurrence of HD and FALS in our patient and three previously reported cases did not appear to be associated with cosegregation in other family members.

Entities:  

Mesh:

Year:  1996        PMID: 8891076     DOI: 10.1007/s004010050539

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  5 in total

1.  Coexistence of Huntington's disease and amyotrophic lateral sclerosis: a clinicopathologic study.

Authors:  Mari Tada; Elizabeth A Coon; Alexander P Osmand; Patricia A Kirby; Wayne Martin; Marguerite Wieler; Atsushi Shiga; Hiroe Shirasaki; Masayoshi Tada; Takao Makifuchi; Mitsunori Yamada; Akiyoshi Kakita; Masatoyo Nishizawa; Hitoshi Takahashi; Henry L Paulson
Journal:  Acta Neuropathol       Date:  2012-06-27       Impact factor: 17.088

2.  Association of genetically proven Huntington's disease and sporadic amyotrophic lateral sclerosis in a 72-year-old woman.

Authors:  Sokratis G Papageorgiou; Alexandra Antelli; Anastasios Bonakis; Evangelos Vassos; Ioannis Zalonis; Nikolaos Kalfakis; Marios Panas
Journal:  J Neurol       Date:  2006-12       Impact factor: 4.849

3.  Amyotrophic lateral sclerosis in a patient with a family history of huntington disease: genetic counseling challenges.

Authors:  Andrea L Smith; James W Teener; Brian C Callaghan; Jack Harrington; Wendy R Uhlmann
Journal:  J Genet Couns       Date:  2014-04-26       Impact factor: 2.537

4.  A case of familial ALS due to multi-system proteinopathy 1 and Huntington disease.

Authors:  Björn Oskarsson; Victoria Wheelock; Michael Benatar; J Paul Taylor; Nanette Joyce; David Chesak; Lee-Way Jin
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2014-09-10       Impact factor: 4.092

5.  Pathogenic Huntingtin Repeat Expansions in Patients with Frontotemporal Dementia and Amyotrophic Lateral Sclerosis.

Authors:  Ramita Dewan; Ruth Chia; Jinhui Ding; Richard A Hickman; Thor D Stein; Yevgeniya Abramzon; Sarah Ahmed; Marya S Sabir; Makayla K Portley; Arianna Tucci; Kristina Ibáñez; F N U Shankaracharya; Pamela Keagle; Giacomina Rossi; Paola Caroppo; Fabrizio Tagliavini; Maria L Waldo; Per M Johansson; Christer F Nilsson; James B Rowe; Luisa Benussi; Giuliano Binetti; Roberta Ghidoni; Edwin Jabbari; Coralie Viollet; Jonathan D Glass; Andrew B Singleton; Vincenzo Silani; Owen A Ross; Mina Ryten; Ali Torkamani; Toshiko Tanaka; Luigi Ferrucci; Susan M Resnick; Stuart Pickering-Brown; Christopher B Brady; Neil Kowal; John A Hardy; Vivianna Van Deerlin; Jean Paul Vonsattel; Matthew B Harms; Huw R Morris; Raffaele Ferrari; John E Landers; Adriano Chiò; J Raphael Gibbs; Clifton L Dalgard; Sonja W Scholz; Bryan J Traynor
Journal:  Neuron       Date:  2020-11-26       Impact factor: 18.688

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.